Human CPN1 activation kit by CRISPRa

CAT#: GA100958

CPN1 CRISPRa kit - CRISPR gene activation of human carboxypeptidase N subunit 1



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (2)
Rabbit Polyclonal Anti-CPN1 Antibody
    • 100 ul

CNY 5,250.00


CPN1 (Myc-DDK-tagged)-Human carboxypeptidase N, polypeptide 1 (CPN1)
    • 10 ug

CNY 3,656.00
CNY 3,990.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CPN1
Locus ID 1369
Kit Components

GA100958G1, CPN1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100958G2, CPN1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100958G3, CPN1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001308
Synonyms CPN; SCPN
Summary Carboxypeptidase N is a plasma metallo-protease that cleaves basic amino acids from the C terminal of peptides and proteins. The enzyme is important in the regulation of peptides like kinins and anaphylatoxins, and has also been known as kininase-1 and anaphylatoxin inactivator. This enzyme is a tetramer comprised of two identical regulatory subunits and two identical catalytic subunits; this gene encodes the catalytic subunit. Mutations in this gene can be associated with angioedema or chronic urticaria resulting from carboxypeptidase N deficiency. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...